Chapter 7 Formation, Persistence and Significance of DNA Adduct Formation in Relation to Some Pollutants from a Broad Perspective

Advances in Molecular Toxicology

Volumn 2, Issue C, 2008, Pages 183-239

  Pfohl Leszkowicz, Annie ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; ACRYLAMIDE; AFLATOXIN B1; AMINOBIPHENYL DERIVATIVE; ARISTOLOCHIC ACID; AROMATIC AMINE; BENZENE; BENZIDINE; BIOLOGICAL MARKER; ETHYLENE OXIDE; GLYCIDAMIDE; OCHRATOXIN; PENTACHLOROPHENOL; POLYCYCLIC AROMATIC HYDROCARBON; STYRENE OXIDE; TOXIN; VINYL CHLORIDE;

ASPERGILLUS FLAVUS; BIOTRANSFORMATION; BLOOD TOXICITY; CANCER GROWTH; CARCINOGENESIS; DNA ADDUCT; DNA POLYMORPHISM; FEMALE; GENETIC POLYMORPHISM; HUMAN; LIVER TOXICITY; MALE; MOUSE; NONHUMAN; POLLUTANT; PRIORITY JOURNAL; RAT; REVIEW; TUMOR PROMOTION;

EID: 75449118958     PISSN: 18720854     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1872-0854(07)02007-3     Document Type: Review

References (224)

1. Møller P., and Wallin H. Adduct formation, mutagenesis and nucleotide excision repair of DNA damage produced by reactive oxygen species and lipid peroxidation product. Mutat. Res. 410 (1998) 271-290
2. Lim-Foster M., and Kelley M.R. DNA repair and gene therapy: implications for translational uses. Environ. Mol. Mutagen. 35 (2000) 71-81
3. Mohrenweiser H.W., and Jones I.M. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation. Mutat. Res. 400 (1998) 15-24
4. Hartwell L.H. Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71 (1992) 543-546
5. Toft N.J., and Arends M.J. DNA mismatch repair and colorectal cancer. J. Pathol. 185 (1998) 123-129
6. Au W.W., and Salama S. Use of biomarkers to elucidate susceptibility to cancer. Environ. Mol. Mutagen. 45 (2005) 222-228
7. Au W.W., Oberheitmann B., and Harms C. Assessing DNA damage and health risk using biomarkers. Mutat. Res. 509 (2002) 153-163
8. Bonassi S., Neri M., and Puntoni R. Validation of biomarkers as early predictors of disease. Mutat. Res. 480-481 (2001) 349-358
9. Bonassi S., and Au W.W. Biomarkers in molecular epidemiology studies for health risk prediction. Mutat. Res. 511 (2002) 73-86
10. Bartsch H., Rojas M., Alexandrov K., and Risch A. Impact of adduct determination on the assessment of cancer susceptibility. Recent Results Cancer Res. 154 (1998) 86-96
11. Au W.W., Sierra-Torres C.H., Cajas-Salazar N., Shipp B.K., and Legator M.S. Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility. Environ. Health Perspect. 107 (1999) 501-505
12. Alexandrov K., Rojas M., Geneste O., Castegnaro M., Camus A.M., Petruzzelli S., Giuntini C., and Bartsch H. An improved fluorometric assay for dosimetry of benzo[a] pyrene diol-epoxide-DNA adducts in smokers's lung: comparisons with toalt bulky adducts and aryl hydrocarbon hydroxylase activity. Cancer Res. 52 (1992) 6248-6253
13. 32P-postlabelling and aryl hydrocarbon hydroxylase activity in lung parenchyma of smokers and ex-smokers. Carcinogenesis 12 (1991) 1301-1305
14. Rojas M., Alexandrov K., Cascorbi I., Brockmöller J., Likhachev A., Pozharisski K., Bouvier G., Aubertin G., Mayer L., Kopp-Schneider A., Roots I., and Batsch H. High benzo(a)pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 Msp/MspI-GSTM1*0/*0 genotypes. Pharmacogenetics 8 (1998) 109-118
15. Hemminki K., Dickey C., Karlsson S., Bell D., Hsu Y., Tsai W.Y., Mooney L.A., Savela K., and Perera F.P. Aromatic DNA adducts in foundry workers in relation to exposure, life style and CYP1A1 and glutathione transferase M1 genotype. Carcinogenesis 18 (1997) 345-350
16. Mooney L.A., Bell D.A., Santella R.M., Van Bennekum A.M., Ottman R., Paik M., Blaneer W.S., Lucier G.W., Covey L., Young T.L., Cooper T.B., Glassman A.H., and Perera F.P. Contribution of genetic and nutritional factors to DNA damage in heavy smokers. Carcinogenesis 18 (1997) 503-509
17. Ichiba M., Hagmar L., Rannug A., Hogstedt B., Alexandrie A.K., Carstensen U., and Hemminki K. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GST1 in chimney sweeps. Carcinogenesis 15 (1994) 1347-1352
18. Whyatt R.M., Bell D.A., Santella R.M., Garte S.J., Jedrychowski W., Gladek-Yarborough A., Cosma G., Manchester D.K., and Young T.-L. Polycyclic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis 19 (1998) 1389-1392
19. Whyatt R.M., Santella R.M., Jedrychowski W., Garte S.J., Bell D.A., Ottman R., Gladek-Yarborough A., Cosma G., Young T.-L., Cooper T.B., Randell M.C., Manchester D.K., and Perera F.P. Relationship between ambient air pollution and DNA damage in Polish mothers and newborns. Environ. Health Perspect. 106 Suppl 3 (1998) 821-826
20. Perera F.P., Jedrychowki W., Rauh V., and Whyatt R.M. Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ. Health Perspect. 107 (1999) 451-460
21. Georgiadis P., Demopoulos N.A., Topinka J., Stephanou G., Stoikidou M., Bekyrou M., Katsouyianni K., Sram R., Autrup H., and Kyrtopoulos S.A. Impact of phase I or phase II enzyme polymorphisms on lymphocyte DNA adducts in subjects exposed to urban air pollution and environmental tobacco smoke. Toxicol. Lett. 149 (2004) 269-280
22. Whyatt R.M., Perera F.P., Jedrychowski W., Santella R.M., Garte S.J., and Bell D.A. Assocation between polycyclic aromatic hydrocarbon-DNA adduct levels in maternal and newborn white blood cells and glutathione-S-transferase P1 and CYP1A1 polymorphism. Cancer Epidemiol. Biomarkers Prev. 9 (2000) 207-212
23. Brescia A., Celotti L., Clonfero E., Neumann H.G., Forni A., Foa V., Pisoni M., Ferri G.M., and Assennato G. The influence of cytochrome P4501A1 and glutathione S-transferase M1 genotypes on biomarker levels in coke oven workers. Arch. Toxicol. 73 (1999) 431-439
24. Merlo F., Andreassen A., Weston A., Pan C.F., Haugen A., Valerio F., Reggiardo G., Fontana V., Garte S., Puntoni R., and Abbondandolo A. Urinary excretion of 1-hydroxypryene as amarker for exposure to urban air levels of polycyclic aromatic hydrocarbons. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 147-155
25. Pavanello S., Gabbani G., Mastrangelo G., Brugnone F., Maccacaro G., and Clonfero E. Influence of GSTM1 genotypes on anti-BPDE-DNA adduct levels in mononuclearwhite blood cells of humans exposed to HAP. Int. Arch. Occup. Environ. Health 72 (1999) 238-246
26. Autrup H., Daneshvar B., Dragsted L.O., Gamborg M., Hansen A.M., Loft S., Okkels H., Nielsen P.R., Raffn E., Wallin H., and Knudsen L.E. Biomarkers for exposure to ambient air pollution. Comparison of carcinogen-DNA adduct levels with other exposure markers and markers for oxidative stress. Environ. Health Perspect. 107 (1999) 233-238
27. Knudsen L.B., Norppa H., Gamborg M.G., Nielsen P.S., Okkels H., Soll-Johanning H., Raffli E., Järventaus H., and Autrup H. Chromosomal aberrations induced by urban air pollution in humans: influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. Cancer Epidemiol. Biomarkers Prev. 8 (1999) 303-310
28. Hou S.M., Lambert B., and Hemminki K. Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis 16 (1995) 1913-1917
29. Butkiewicz D., Grzybowska E., Hemminki K., ØVREBØ S., Augen A.A., Motykiewicz G., and Chorazy M. Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1, CYP2D6 and GSTM1 genetic polymorphism. Mutat. Res. 415 (1998) 97-108
30. Pan G., Hanaoka T., Yamano Y., Hara K., Ichiba M., Wang Y., Zhang J., Feng Y., Shujuan Z., Guan D., Gao G., Liu N., and Takahashi K. A study of multiple biomarkers in coke oven workers - a cross-sectional study in China. Carcinogenesis 19 (1998) 1963-1968
31. Zhang J., Ichiba M., Feng Y., Pan G., Hanaoka T., Yamano Y., Hara K., Takaha1shi K., and Tomokuni K. Aromatic DNA adducts in coke-oven workers, in relation to exposure, lifestyle and genetic polymorphism of metabolic enzymes. Int. Arch. Occup. Environ. Health 73 (2000) 127-135
32. Rojas M., Cascorbi I., Alexandrov K., Kriek E., Auburtin G., Mayer L., Kopp-Schneider A., Roots I., and Bartsch H. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blodd cells by CYP1A1, GSTM1 and GSTT. Carcinogenesis 21 (2000) 35-41
33. Rojas M., Alexandrov K., Cascorbi I., Brockmöller J., et al. High benzo(a)pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 Msp/MspI-GSTM1*0/*0 genotypes. Pharmacogenetics 8 (2000) 109-118
34. Sram R.J., Binkova B., Dejmek J., Chvatalova I., Solansky I., and Topinka J. Association of DNA adducts and genotypes with birth weight. Mutat. Res. 608 (2006) 121-128
35. Viezzer H., Norppa H., Clonfero E., Gabbani G., Mastrangelog, Hirvonen A., and Celotti L. Influence of GSTM1, GSTT1, GSP1 and PHX gene polymorphisms on DNA adduct level and HPRT mutant frequency in coke-oven workers. Mutat. Res. 431 (1999) 259-269
36. Leng S., Dai Y., Niu Y., Pan Z., Li X., Cheng J., He F., and Zheng Y. Effects of genetic polymorphisms of metabolic enzymes on cytokinesis-block micronucleus in peripheral blood lymphocyte among coke-oven workers. Cancer Epidemio., Biomarkers Prev. 13 (2004) 1631-1639
37. Ryberg D., Skaug V., Hewer A., Phillips D.H., Harries L.W., Wolf C.R., Ogreid D., Ulvik A., Vu P., and Haugen A. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis 18 (1997) 1285-1289
38. Kuljukka-Rabb T., Nylund L., and Vaaranta R. The effect of relevant genotypes on PAH exposure-related biomarkers. J. Expo. Anal. Environ. Epidemiol. 12 (2002) 81-91
39. Lazarus P., Sheikh S.N., Ren Q., Schantz S.P., Stern J.C., Richie Jr J.P., and Park J.Y. p53, but not p16 mutations in oral squamous cell carcinomas are associated with specific CYP1A1 and GSTM1 polymorphic genotypes and patient tobacco use. Carcinogenesis 19 (1998) 509-514
40. Przygodzki R.M., Benett W.P., Guinee D.G., Khan M.A., Freedman A., Shields P.G., Travis W.D., Jett J.R., Tazelaar H., Pairolero P., Trastek V., Liotta L.A., Harris C.C., and Caporaso N.E. P53 mutation spectrum in relation to GSTM1, CYP1A1 and CYP2E1 in surgically treated patients witn non-small cell lung cancer. Pharmacogenetics 8 (1998) 503-511
41. Bartsch H., Rojas M., Nair U., Nair J., and Alexandrov K. Genetic susceptibility and DNA adducts: studies in smokers, tobacco chewers, and coke-oven workers. Cancer Detect. Prev. 23 (1999) 445-453
42. Bartsch H., Nair U., Risch A., Rojas M., Wikman H., and Alexandrov K. Genetic polymorphism of CYP genes alone or in combination, as a risk modifier of tobacco-related cancer. Cancer Detect. Prev. 9 (2000) 3-28
43. Pavanello S., Pulliero A., Siwinska E., Mielzynska D., and Clonfero E. Reduced nucletodie excision repair and GSTM1-null genotypes influence anti-B[a]PDE-DNA adduct levels in mononuclear white blood cells of highly PAH-exposed coke oven workers. Carcinogenesis 26 (2005) 169-175
44. Hou S.M., Falt S., Angelini S., Yang K., Nyberg F., Lambert B., and Hemminki K. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 23 (2002) 599-603
45. Palli D., Russo A., Masala G., Saieva C., Guarrera S., Carturan S., Munnia A., Matullo G., and Peluso M. DNA adduct levels and DNA repair polymorphisms in traffic-exposed workers and a general population sample. Int. J. Cancer 94 (2001) 121-127
46. Leng S., Cheng J., Zhang L., Niu Y., Dai Y., Pan Z., Li B., He F., and Zheng Y. The association of XRCC1 halotypes and chromosomal damage levels in peripheral blood lymphocyte among coke-oven workers. Cancer Epidemiol., Biomarkers Prev. 14 (2005) 1295-1301
47. Rothman N., Smith M.T., Hayes R.B., Traver R.D., Hoener B., Campleman S., Li G.L., Dosemeci M., Linet M., Zhang L., Xi L., Wacholder S., LU W., Meyer K.B., Titenko-Holland N., Stewart J.T., Yin S., and Ross D. Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C-->T mutation and rapid fractional excretion of chloroxazone. Cancer Res. 57 (1997) 2839-2842
48. Moran J.L., Siege L.D., and Ross D. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H quinine oxidoreductase 1 (NQO1) to benzene toxicity. Proc. Natl. Acad. Sci. 96 (1999) 8150-8155
49. Xu X., Wiencke J.K., Niu T., Wang M., Watanabe H., Kelsey K.T., and Christiani D.C. Benzene exposure, glutathione S-transferase theta homozygous deletion, and sister chromatid exchanges. Am. J. Ind. Med. 33 (1998) 157-163
50. Huang C.Y., Huang K.L., Cheng T.J., WANG J.D., and HSIEH L.L. The GST T1 and CYP2E1genotypes are possible factors causing vinyl chloride induced abnormal liver function. Arch. Toxicol. 71 (1997) 482-488
51. Swenberg J.A., Fedtke N., Ciroussel F., Barbin A., and Bartsch H. Etheno adducts formed in DNA of vinyl chloride-exposed rats are highly persistent in liver. Carcinogenesis 13 (1992) 727-729
52. Wong R.H., Wang J.D., Hsieh L.L., Du C.L., and Cheng T.J. Effects on sister chromatid exchange frequency of aldehyde dehydrogenase 2 genotype and smoking in vinyl chloride workers. Mutat. Res. 420 (1998) 99-107
53. Li Y., Zhou M., Marion M.-J., Lee S., and Brandt R.P.W. Polymorphisms in glutathione S-transferases in French vinyl chloride workers. Biomarkers 10 (2005) 72-79
54. Soussi T. Le gène suppresseur de tumeur p53. Bull. Cancer 80 (1993) 96-101
55. wong R.H., Wang J.D., Hsieh L.L., and Cheng T.J. XRCC1, CYP2E1 and ALDH2 genetic polymorphisms and sister chromatid exchange frequency alterations amongst vinyl chloride monomer-exposed polyvinyl chloride workers. Arch. Toxicol. 77 (2003) 433-440
56. Li Y., Marion M.-J., Rundle A., and Brandt-Rauf P.W. A common polymorphism in XRCC1as a biomarker of susceptibility for chemically induced genetic damage. Biomarkers 8 (2003) 408-414
57. Kelsey K.T., Wiencke J.K., Ward J., Bechtold W., and Fajen J. Sister-chromatid exchanges, glutathione S-transferase theta deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers. Mutat. Res. 335 (1995) 267-273
58. Abdel-Rahman S.Z., Ammenheuser M.M., and Ward J.B. Human sensitivity to 1,3-butadiène: role of microsomal epoxide hydrolase polymorphism. Carcinogenesis 22 (2001) 415-423
59. Abdel-Rahman S.Z., El-Zein R.A., Ammenheuser M.M., Yang T., Stock T.H., Morandi M., and Ward J.B. Variability in human sensitivity to 1,3-butadiene: influence of the allelic variants of the microsomal epoxide hydrolase gene. Environ. Mol. Mutagen. 41 (2003) 140-146
60. Wiencke J.K., Pemble S., Ketterer B., and Kelsey K.T. Gene deletion of glutathione S-transferase theta: correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol. Biomarkers Prev. 4 (1995) 253-259
61. Norppa H., Hirvonen A., Jarventaus H., Uuskula M., Tasa G., Ojajarvi A., and Sorsa M. Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity tosister chromatid exchange induction by diepoxybutane in cultured humanlymphocytes. Carcinogenesis 16 (1995) 1261-1264
62. Pelin K., Hirvonen A., and Norppa H. Influence of erythrocyte glutathione S-transferase T1 on sister chromatid exchanges induced by diepoxybutane in cultured human lymphocytes. Mutagenesis 11 (1996) 213-215
63. Bernardini S., Hirvonen A., Pelin K., and Norppa H. Induction of sister chromatidexchange by 1,2-epoxy-3-butene in cultured human lymphocytes: influence of GSTT1 genotype. Carcinogenesis 19 (1998) 377-380
64. Bernardini S., Pelin K., Peltonen K., Jarventaus H., Hirvonen A., Neagu C., Sorsa M., and Norppa H. Induction of sister chromatid exchange by 3,4-expoxybutane-1,2-diol in cultured human lymphocytes of different GSTT1and GSTM1 genotypes [published erratum appears in Mutat. Res. April 24, 390(1-2) (1997):199]. Mutat. Res. 361 (1996) 121-127
65. Cheng T.-J., Hwang S.-J., Kuo H.-W., Luo J.-C., and Chang M.J.W. Exposure to epichiorohydrin and dimethylformamide, glutathione S-transferases and sister chromatid exchange frequencies in peripheral lymphocytes. Arch. Toxicol. 73 (1999) 282-287
66. Muller M., Kramer A., Angerer J., and Hallier E. Ethylene oxide-protein adductformation in humans: influence of glutathione-S-transferase polymorphisms. Int. Arch. Occup. Environ. Health 71 (1998) 499-502
67. Teixeira J.P., Gaspar J., Martinho G., Silva S., Ridrigues S., Mayan O., Martin E., Farmer P.B., and Rueff J. Aromatic DNA adduct levels in coke oven workers: correlation with polymorphisms in gene GSTP1, GSTM1, GSTT1 and CYP1A1. Mutat. Res. 517 (2002) 147-155
68. Vodicka P., Tuimala J., Stetina R., Kumar R., Manini P., Naccarati A., Maestri L., Vodickova L., Kuricova M., Järventaus H., Majvaldova Z., Hirvonen A., Imbriani M., Mutti A., Migliore L., Norppa H., and Kari Hemminki K. Cytogenetic markers, DNA single-strand breaks, urinary metabolites, and DNA repair rates in styrene-exposed lamination workers. Environ. Health Perspect. 112 (2004) 867-871
69. Vodicka P., Soucek P., Tastes A.D., Dusinska M., Sarmanova J., Zamecnikova M., Vodicka L., Kaskinenem, Zwart F.A., Natarajan A.T., and Hemminki K. Association between genetic polymorphism and biomarker in styrene-exposed workers. Mutat. Res. 482 (2001) 89-103
70. Üusküla M., Järventaus H., Hirvonen A., Sorsa M., and Norppa H. Influence of GSTM1 genotype on sister chromatid exchange induction by styrene-7,8-oxide and 1,2-epoxy-3-butene in cultured human lymphocyes. Carcinogenesis 16 (1995) 947-950
71. Sorsa M., Osterman-Golkar S., Peltonen K., Saarikoski S.T., and Sram R. Assessment of exposure to butadiene in the process industry. Toxicology 113 (1996) 77-83
72. Sram R.J., Rossner P., Peltonen K., Podrazilova K., Mrackova G., Demopoulos N.A., Stephanou G., Vlachodimitropoulos D., Darroudi F., and Tates A.D. Chromosomal aberrations, sister-,chromatid exchanges, cells with high frequency of SCE, micronuclei and comet assay parameters in 1, 3- butadiene-exposed workers. Mutat. Res. 419 (1998) 145-154
73. Laffon B., Pasaro E., and Mendez J. Evaluation of genotoxic effects in a group of workers exposed to low levels of styrene. Toxicology 171 (2002) 175-186
74. Ollikainen T., Hirvonen A., and Norppa H. Influence of GSTT1 genotype on sister chromatid exchange induction by styrene-7,8-oxide in cultured humanlymphocytes. Environ. Mol. Mutagen. 31 (1998) 311-315
75. Laffon B., Perez-Cadahia B., Pásaro B., and Méndez J. Effect of epoxide hydrolase and glutathione S-transferase genotypes on the induction of micronuclei and DNA damage by styrene-7,8-oxide in vitro. Mutat. Res. 536 (2003) 49-59
76. Laffon B., Perez-Cadahia B., Pasaro B., and Mendez J. Individual sensitivity to DNA damage induced by styrene in vitro: influence of cytochrome P450, epoxide hydrolase and glutathione S-transferase genotypes. Toxicology 186 (2003) 131-141
77. Hayes R.B., Zhang L., Yin S., Swenberg J.A., Xi L., Wiencke J., Bechtold W.E., Rothman N., Haas R., O'Neill J.P.O., Zhang D., Wiemels J., Dosemeci M., Li G., and Simth M.T. Genotoxic markers among butadiene polymer workers in China. Carcinogenesis 21 (2000) 55-62
78. Fustioni S., Soleo L., Warholm M., Begeman P., Rannung A., Neumann H.G., Swenberg J.A., Vimercati L., and Colombi A. Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans. Cancer Epidemiol. Biomarkers Prev. 11 (2002) 1082-1090
79. Zhao C., Vodicka P., Sram R.J., and Hemminki K. DNA adduct of 1,3-Butadiene in humans: relationships to exposure, GST genotypes, single-strand breaks, and cytogenetic end points. Environ. Mol. Mutagen. 37 (2001) 226-230
80. Warholm M., Rannung A., Fustioni S., Begemann P., Soleo L., Barale R., Järventhaus R., and Norppa H. Influence of metabolic genotypes on chromosome aberrations in butadiene exposed workers. Toxicologist 72 S1 (2003) 98
81. Thier R., Pemble S.E., Kramer H., Taylor J.B., Guengerich F.P., and Ketterer B. Human glutathione S-transferase T1-1 enhances mutagenicity of 1,2-dibromoethane, dibromomethane and 1,2,3,4-diepoxybutane in Salmonella typhimurium. Carcinogenesis 17 (1996) 163-166
82. Their R., Lewalter J., Kempkes M., Selinski S., Bruning T., and Bolt H.M. Haemoglobin adducts of acrylonitrile and ethylene oxide in acrylonitrile workers, dependent on polymorphisms of the glutathione transferases GSTT1 and GSTM1. Arch. Toxicol. 73 (1999) 197-202
83. Yong L.C., Schulte P.A., Wiencke J.K., Boeniger M.F., Connally L.B., Walker J.T., Whelan E.A., and Ward E.M. Hemoglobin adducts and sister chromatid exchanges in hospital workers exposed to ethylene oxide: effects of glutathione S-transferase T1 and M1 genotypes. Cancer Epidemiol. Biomarkers Prev. 10 (2001) 539-550
84. Migliore L., Naccarati A., Coppede F., Bergamaschi E., De Palma G., Voho A., Manini P., Jarventaus H., Mutti A., Norppa H., and Hirvonena A. Cytogenetic biomarkers, urinary metabolites and metabolic gene polymorphisms in workers exposed to styrene. Pharmacogenet. Genomics 16 (2006) 87-99
85. Rossi C., Buschini A., and Poli P. Individual susceptibility and DNA damage assessed by the COMET assay in workers occupationally exposed to styrene. VII Annual congress of the Italian environmental mutagen society, Cortona October 6-8 (1999) 27
86. Goderis L., De Boeck M., Haufroid V., Emmery M., Mateuca R., Gardinal S., Kirsch-Volders M., Veulemans H., and Lison D. Influence of genetic polymorphisms on biomarkers of exposure and genotoxic effects in styrene-exposed workers. Environ. Mol. Mutagen. 44 (2004) 293-303
87. Conolly R.B., Andjelkovith D.A., and Casanova M. Multidisciplinary iterative examination of the mechanism of formaldehyde carcinogenicity: the basis for better risks assessment. CIIT activities, Research Triangle Park, NC, Chemical Industry Institute of Toxicology 15 (1995) 1-11
88. Conaway M., Whysner J., Verna L.K., and Williams G.M. Formaldehyde mechanistic data and risk assessment: endogenous protection from DNA adduct formation. Pharmacol. Ther. 71 (1996) 29-55
89. Rothman N., Hayes R.B., Zenser T.V., Demarini D.M., Bi W., Hirvonen A., Talaska G., Bhatnagar V.K., Caporaso N.E., Brooks L.R., Lakshmi V.M., Feng P., Kashyap S.K., Youx, Eischen B.T., Kashyap R., Shelton M.L., Hsu F.F., Jaeger M., Parikh D.J., Davisbb, Yin S., and Bell D.A. The glutathione S-transferase M1 (GSTM1) null genotype and benzidine-associated bladder cancer, urine mutagenicity, and exfoliated urothelial cell DNA adducts. Cancer Epidemiol. Biomarkers Prev. 5 (1996) 979-983
90. Rothman N., Talaska G., Hayes R.B., Bhatnagar V.K., Bell D.A., Lakshmi V.M., Kashyap S.K., Dosemeci M., Kashyap R., Hsu F.F., Jaeger M., Hirvonen A., Parikh D.J., Davis B.B., and Zenser T.V. Acidic urine pH is associated with elevated levels of free urinary benzidine and N-acetylbenzidine and urothelial cell DNA adducts in exposed workers. Cancer Epidemiol. Biomarkers Prev. 6 (1997) 1039-1042
91. Kadlubar F.F. DNA adducts of carcinogenic aromatic amines. IARC Publ. 125 (1994) 199-216
92. Hein D.W. Molecular genetics and function of NAT1 and NAT2: role of aromatic amine metabolism and carcinogenesis. Mutat. Res. 506-507 (2002) 65-77
93. G. Talaska, A.Z.S.S. Al-Juburi, F.F. Kadlubar, Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct, PNAS 88 (1991) 5350-5354.
94. Talaska G. Aromatic amines and human urinary bladder cancer: exposure sources and epidemiology. J. Environ. Sci. Health, Part C 21 (2003) 29-43
95. Badawi A.F., Hirvonen A., Bell D.A., Lang N.P., and Kadlubar F.F. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res. 55 (1995) 5230-5237
96. Thompson P.A., Seyedi F., Lang N.P., Macleod S.L., Wogan G.N., Anderson K.E., Tang Y.M., Coles B., and Kadlubar F.F. Comparison of DNA adducts levels associated with exogenous and endogenous exposures in human pancreas in relation to metabolic genotype. Mutat. Res. 424 (1999) 263-274
97. Vineis P., Bartsch H., Caporaso N., Harrington A.M., Kadlubar F.F., Landi M.T., Malaveille C., Shields P.G., Skipper P., and Talaska G. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens. Nature 369 (1994) 154-156
98. Dallinga J.W., Pachen D.M., Wijnhoven S.W., Breedijk A., van't Veer L., Wigbout G., van Zandwijk N., Maas L.M., van Agen E., Kleinjans J.C., and van Schooten F.J. The use of 4-aminobiphenyl hemoglobin adducts and aromatic DNA adducts in lymphocytes of smokers as biomarkers of exposure. Cancer Epidemiol. Biomarkers Prev. 7 (1998) 571-577
99. Riffelman M., Muller G., Schmieding W., Popp W., and Norpoth K. Biomonitoring of urinary aromatic amines and arylamine haemoglobin adducts in exposed workers and non exposed control persons. Int. Arch. Occup. Environ. Health 68 (1995) 36-43
100. Landi M.T., Zocchetti C., Bernucci I., Kadlubar F.F., Tannenbaum S., Skipper P., Bartsch H., Malaveille C., Shields P., Caporaso N.E., and Vineis P. Cytochrome P4501A2: enzyme induction and genetic control in determining 4-aminobiphenyl-hemoglobin adduct levels. Cancer Epidemiol. Biomarkers Prev. 5 (1996) 693-698
101. Landi S., Ponzanelli I., Hirvonen A., Norppa H., and Barale R. Repeated analysis of sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes: effect of glutathione S-transferase T1 and M1 genotype. Mutat. Res. 351 (1996) 79-85
102. Nguyen T.N., Bertagnolli A.B., Villalta P.W., Bühlmann P., and Sturla S.J. Characterization of a deoxyguanosine adduct of tetrachlorobenzoquinone: dichlorobenzoquinone-1,N2-etheno-2′-deoxyguanosine. Chem. Res. Toxicol. 18 (2005) 1770-1776
103. Vaidyanathan V.G., Villalta P.W., and Sturla S.J. Nucleobase-dependent reactivity of a quinone metabolite of pentachlorophenol. Chem. Res. Toxicol. 20 (2007) 913-919
104. Dai J., Wright M.W., and Manderville R.A. An oxygen-bonded C8-deoxy-guanosine nucleoside adduct of pentachlorophenol by peroxidase activation: evidence for ambident C8 reactivity by phenoxyl radicals. Chem. Res. Toxicol. 16 (2003) 817-821
105. Dai J., Sloat A.L., Wright M.W., and Manderville R.A. Role of phenoxyl radicals in DNA adduction by chlorophenol xenobiotics following peroxidase activation. Chem. Res. Toxicol. 18 (2005) 771-779
106. Goldman R., Claycamp G.H., Sweetland M.A., Sedlov A.V., Tyurin V.A., Kisin E.R., Tyurina Y.Y., Ritov V.B., Wenger S.L., Grant S.G., and Kagan V.E. Myeloperoxidase catalyzed redox cycling of phenol promotes lipid peroxidation and thiol oxidation in HL-60 cells. Free Radical Biol. Med. 27 (1999) 1050-1063
107. Waidyanatha S., Lin P.-H., and Rappaport S.M. Characterization of chlorinated adducts of hemoglobin and albumin following administration of pentachlorophenol to rats. Chem. Res. Toxicol. 9 (1996) 647-653
108. Manderville R.A., and Pfohl-Leszkowicz A. Genotoxicity of chlorophenols and ochratoxin A. Advance Mol. Toxicol. 1 (2006) 73-118
109. Tozlovanu M., Faucet-Marquis V., Pfohl-Leszkowicz A., and Manderville R.A. Genotoxicity of the hydroquinone metabolite of ochratoxin A: structure-activity relationships for covalent DNA adduction. Chem. Res. Toxicol. 19 (2006) 1241-1247
110. Pfohl-Leszkowicz A., and Manderville R.A. Ochratoxin A: an overview on toxicity and carcinogenicity in animals and humans. Mol. Nutr. Food Res. 51 (2007) 61-99
111. Pfohl-Leszkowicz A., Pinelli E., Bartsch H., Mohr U., and Castegnaro M. Sex- and strain-specific expression of CYPs involved in ochratoxin A genotoxicity and carcinogenicity in rats. Mol. Carcinog. 23 (1998) 78-85
112. Pfohl-Leszkowicz A., Tozlovanu M., Manderville R.A., Peraica M., Castegnaro M., and Stefanovic V. New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor. Mol. Nutr. Food Res. 51 (2007) 1131-1146
113. Kamataki T., Maeda K., Yamazoe Y., Nagai T., and Kato R. Sex difference of cytochrome P-450 in the rat:purification, characterization, and quantitation of constitutive forms of cytochrome-P450 from liver microsomes of male and female rats. Arch. Biochem. Biophys. 225 (1983) 758-777
114. Gustafsson J.A., Mode A., Norstedt G., and Skett P. Sex steroid induced changes in hepatic enzymes. Annu. Rev. Physiol. 45 (1983) 51-60
115. Atanasova S.Y., Von Ahsen N., Toncheva D., Dimitrov T.G., Oellerich M., and Armstrong V.W. Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN). Clin. Biochem. 38 (2005) 223-228
116. Pfohl-Leszkowicz A., Bartsch H., Azémar B., Mohr U., Estève J., and Castegnaro M. Mesna protects rats against nephrotoxicity but not carcinogenicity induced by ochratoxin A, implicating two separate pathways. Facta Universitatis, Series Medicine Biology 9 (2002) 57-63
117. Faucet-Marquis V., Pont F., Størmer F., Rizk T., Castegnaro M., and Pfohl-Leszkowicz A. Evidence of a new dechlorinated OTA derivative formed in opossum kidney cell cultures after pre-treatment by modulators of glutathione pathways. Correlation with DNA adducts formation. Mol. Nutr. Food Res. 50 (2006) 531-542
118. Andonova I.E., Sarueva R.B., Horvath A.D., Simeonov V.A., Dimitrov P.S., Petropoulos E.A., and Ganev V.S. Balkan endemic nephropathy and genetic variants of glutathione S-transferases. J. Nephrol. 17 (2004) 390-398
119. A. Pfohl-Leszkowicz, P. Guerre, P. Galtier, Métabolisation des mycotoxines dans: Lavoisier, Tec & doc. Mycotoxines: Evaluation et gestion du risque 1999, chapitre 3, pp. 37-55.
120. M. Castegnaro, A. Pfohl-Leszkowicz, Aflatoxines dans: Lavoisier, Tec & doc. (ed) Mycotoxines: Evaluation et gestion du risque 1999, chapitre 8, pp. 199-228.
121. Lunn R.M., Langlois R.G., Hsieh L.L., Thompson C.L., and Bell D.A. XRCC1 polymorphisms: effect on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res. 59 (1999) 2557-2561
122. Mengs U., Lang W., and Poch J.A. The carcinogenic action of aristolochic acid in rats. Arch. Toxicol. 51 (1982) 107-119
123. Mengs U. On the histopathogenesis of rat forestomach carcinoma caused by aristolochic acid. Arch. Toxicol. 52 (1983) 209-220
124. Mengs U. Tumour induction in mice following exposure to aristolochic acid. Arch. Toxicol. 61 (1988) 504-505
125. Xing B., Chen L., Zhou L., Jin L., and Liu F. Experimental study on the carcinogenicity of aristolochic acid. Guangxi Yixue 4 (1982) 118-120
126. Burlinson B. An in vivo unscheduled DNA synthesis (UDS) assay in the rat gastric mucosa: preliminary development. Carcinogenesis 10 (1989) 1425-1428
127. Routledge M.N., Orton T.C., Lord P.G., and Garner R.C. Effect of butylated hydroxyanisole on the level of DNA adduction by aritstolochic acid in the rat forestomach and liver. Jpn. J. Cancer Res. 18 (1990) 220-224
128. Turesky R.J. Dna adducts of heterocyclic aromatic amines, arylazides and 4-nitroquinoline 1-oxide. IARC Publ. 125 (1994) 217-228
129. Turesky R.J., and Vouros P. Formation and analysis of heterocyclic aromatic amine-DNA adducts in vitro and in vivo. J. Chromatogr. B 802 (2004) 155-166
130. Nebert D.W., and Dalton T.P. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nat. Rev. 6 (2006) 947-960
131. Cortesi V., and Thomas D.C. Toxicokinetic genetics: an approach to gene-environment and gene-gene interactions in complex metabolic pathways. IARC Sci. Publ. 157 (2004) 127-150
132. Fost U., Tornqvist M., Leutbecher M., Granath F., Hallier E., and Ehrenberg L. Effects of variation in detoxification rate on dose monitoring through adducts. Hum. Exp. Toxicol. 14 (1995) 201-203
133. Bartsch H. Suties on biomarkers in cancer etiology and prevention: a summary and challenge of 20 years of interdisciplinary research. Mutat. Res. 462 (2000) 255-279
134. Vaury C., Laine R., Noguiez P., Decoppet P., Jaulin C., Praz F., Pompn D., and Amorgueret M. Human glutathione S-transferase M1 null genotype is associated with a high inducticibility of cytochrome 1A1 gene transcription. Cancer Res. 55 (1995) 5520-5523
135. Pluth J.M., Ramsey M.J., and Tucker J.D. Role of maternal exposures and newborn genotype and chromosome aberrations frequencies. Mutat. Res. 465 (2000) 101-111
136. Cheng T.J., Christiani D.C., Xu X., Wain J.C., Wiencke J.K., and Kelsey K.T. Glutathione-S-transferase mu genotype, diet, and smoking as determinants of sister chromatid exchange frequency in lymphocytes. Cancer Epidemiol. Biomarkers Prev. 4 (1995) 535-542
137. Laczmanska I., Gil J., Karpinski P., Stembalska A., Kozlowka J., Busza H., Trusewicz A., Pesz K., Ramsey D., Schlade-Bartusiak K., Blin N., and Sasiadek M.M. Influence of polymorphism in xenobiotic-metabolizing genes and DNA-repair genes on diepoxybutane-induced frequency. Environ. Mol. Mutagen. 47 (2006) 666-673
138. Robert J., Le Morvan V., Smith D., Pourquier P., and Bonnet J. Predicting drug response and toxicity based on gene polymorphisms. Crit. Rev. Oncol./Haematology 54 (2005) 171-196
139. Goode E.L., Ulrich C.M., and Potter J.D. Polymorphism in DNA repair genes and associations with cancer. Cancer Epidemiol., Biomarkers Prev. 11 (2002) 1513-1530
140. Vodicka P., Kumar R., Stetina R., Sanyal S., Soucek P., Haufroid V., Dusinka M., Kuricova M., Zamecnikova M., Musak L., Buchancova J., Norppa H., Hirvonen A., Vodickova L., Naccarati A., Matousu Z., and Hemminki K. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 25 (2004) 757-763
141. Vodicka P., Kumar R., Stetina R., Musak L., Soucek P., Haufroid V., Sasiadek M., Vodickova L., Naccarati A., Sedokova J., Sanyal S., Kuricova M., Brsiak V., Norppa H., Buchancova J., and Hemminki K. Markers of individual susceptibility and DNA repair rate in workers exposed to xenobiotics in a tire plant. Environ. Mol. Mutagen. 44 (2004) 283-292
142. Butkiewicz D., Popanda O., Risch A., Edler L., Dienemann H., Schulz V., Kayser K., Drings P., Bartsch H., and Schmezer P. Association between risk for lung adenocarcinoma and a (-4) G to A polymorphism in the XPA gene. Cancer Epidemiol., Biomarkers Prev. 13 (2004) 2242-2246
143. Duell E.J., Wienckej K., Cheng T.J., Varkonyi A., Zuoi Z.F., Ashok T.D.S., Mark E.J., Wain J.C., Christiani D.C., and Kelsey K.T. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 21 (2000) 965-971
144. Ma M., Umemura T., Mori, Gong Y., Saijo Y., Sata F., Kawai T., and Kishi R. Influence of genetic polymorphism of sturen-metabolizing enzymes and smoking habits on levels of urinary metabolites after occupational exposure to styrene. Toxicol. Lett. 160 (2005) 84-91
145. Teixeira J.P., Gaspar J., Silva S., Torres J., Silva S.N., Azevedo M., Neves P., Laffon B., Mendez J., Goncalves, Mayan O., Farmer P.B., and Rueff J. Occupational exposure to styrene: modulation of cytogenetic damage and levels of urinary metabolites of styrene by polymorphisms in genes CYP2E1, EPHX1, GSTM1, GSTT1 and GSTP1. Toxicology 195 (2004) 231-242
146. Sturla S.J. DNA adduct profiles: chemical approaches to addressing the biological impact of DNA damage from small molecules. Curr. Opin. Chem. Biol. 11 (2007) 293-299
147. Vainio H. Use of biomarkers in risk assessment. Int. J. Envrion. Health 204 (2001) 91-102
148. Brambilla G., and Martelli A. Failure of the standard battery of short-term tests in detecting some rodent and human genotoxic carcinogens. Toxicology 196 (2004) 1-19
149. Norppa H. Cytogenetic markers of susceptibility: influence of polymorphiccarcinogen-metabolizing enzymes. Environ. Health Perspect. 105 Suppl 4 (1997) 829-835
150. Norppa H., Bemardini S., Wikman H., Järventaus H., Rosenberg C., Bolognesi C., and Hirvonen A. Cytogenetic biomarkers in occupational exposure to dii socyanates: influence of genetic polymorphisms of metabolic enzymes. Environ. Mol. Mutagen. 35 Suppl. 31 (2000) 45
151. Norppa H., Lindholm C., Ojajärvi A., Salomaa S., and Hirvonen A. Metabolic polymorphisms and frequency of chromosomal aberrations. Environ. Mol. Mutagen. 37 Suppl. 32 (2001) 58
152. Norppa H. Genetic susceptibility, biomarker responses, and cancer. Mutat. Res. 544 (2003) 339-348
153. Norppa H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol. Lett. 149 (2004) 309-334
154. Pavanello S., and Clonfero E. Biological indicators of genotoxic risk and metabolic polymorphisms. Mutat. Res. 463 (2000) 285-308
155. Pesch B., Brüning T., Frentzel-Beyme R., Johnen G., Harth V., Hoffmann W., Ko Y., Ranft U., Traugott U.G., Their R., Taeger D., and Bolt H.M. Challenges to environmental toxicology and epidemiology: where do we stand and which way do we go?. Toxicol. Lett. 151 (2004) 255-265
156. Boerrigter M.E.T.I., Wei J.Y., and Vijg J. Induction and repair of benzo(a)pyrene-DNA adducts in C57BL/6 and BALB/c mice: association with aging and longevity. Mech. Ageing Dev. 82 (1995) 31-50
157. Talaska G., Jaeger M., Reilman R., Collins T., and Warshawsky D. Chronic, topical exposure to benzo(a)pyrene induces relatively high steady-state levels of DNA adducts in target tissues and alter kinetics of adduct loss. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 7789-7793
158. Poirier M.C., Beland F.A., Deal F.H., and Swenberg J.A. DNA adduct formation and removal in specific liver cell populations during chronic dietary administration of 2-acetylaminofluorene. Carcinogenesis 10 (1989) 1143-1145
159. Giles A.S., Seidel A., and Philipps D.H. Covalent DNA adducts formed in mouse epidermis by benzo[g]chrysene. Carcinogenesis 17 (1996) 1331-1336
160. Renault D., Brault D., Lossouarn Y., Perin-Roussel O., Taras-Valero D., Perin F., and Thybaud V. Kinetics of DNA adduct formation and removal in mouse hepatocytes following in vivo exposure to 5,9-dimethyldibenzo[c,g]carbazole. Carcinogenesis 21 (2000) 289-294
161. Culp S.J., Warbritton A.R., Sith B.A., Li E.E., and Beland F.A. DNA adduct measurement, cell proliferation and tumor mutation induction in relation to tumor formation in B6C3F1 mice fed coal tar or benzo[a]pyrene. Carcinogenesis 21 (2000) 1433-1440
162. Ingram A.J., Phillips J.C., and Davies S. DNA adducts produced by oils, oil fraction and polycyclic aromatic hydrocarbons in relation to repair processes an skin carcinogenesis. J. Appl. Toxicol. 20 (2000) 165-174
163. Lewtas J., Walsh D., Wiliams R., and Dobias L. Air pollution exposure DNA adduct dosimetry in humans and rodents: evidence for non-linearity at high doses. Mutat. Res. 378 (1997) 51-63
164. Lutz W.K. Dose-response relationship and low dose extrapolation in chemical carcinogenesis. Carcinogenesis 11 (1990) 1243-1247
165. Amat A., Burgeot T., Castegnaro M., and Pfohl-Leszkowicz A. Genotoxic impact of ERIKA fuel (Fuel N°2) on fish liver (Solea solea). In: Robert D., Lichtfouse E., and Scwhartzbauer J. (Eds). Environmental Chemistry: Green Chemistry and Pollutant in Ecosystems (2005), Springer, Heidelberg 743-756
166. Amat A., Burgeot T., Castegnaro M., and Pfohl-Leszkowicz A. DNA adducts in fish following an oil spill exposure. Environ. Chem. Lett. 4 (2006) 93-99
167. Amat A., Castegnaro M., Burgeot T., and Pfohl-Leszkowicz A. DNA adducts as a biomarker of pollution - field study on the genotoxic impact evolution of the Erika oil spill on mussels (Mytilus edulis) over an eleven months period. Polycyclic Aromatic Compounds 24 (2004) 713-732
168. Mooney L.A., Santella R.M., Covey L., Jeffrey A.M., Bigbee W., Randall M.C., Cooper T.B., Ottman R., Tsai W.Y., Wazneh L., Glassman A.H., Young T.L., and Perera F.P. Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiol. Biomarkers Prev. 4 (1995) 627-634
169. Van Delft J.H.M., Steenwinkel M.J.S.T., Van Asten J.G., De Vogel N., Bruijntjes-Rozier T.C., Schouten T., Cramers P., Maas L., Van Herwijnen M.H., Van Schooten F.J., and Hopmans P.M.J. Biological monitoring the exposure to polycyclic aromatic hydrocarbons of coke oven workers in relation to smoking and genetic polymorphisms for GSTM1 and GSTT1. Ann. Occup. Hyg. 45 (1998) 395-408
170. Van Delft J.H.M., Baan R.A., and Roza L. Biological effect markers for exposure to carconogenic compound and their relevance for risk assessment. Crit. Rev. Toxicol. 28 (1998) 477-510
171. Nesnow S., Ross J.A., Nelson G., Holden K., Erexson G., Kligerman A., and Gupta R.C. Quantitative and temporal relationships between DNA adduct formation in target and surrogate tissues: implications for biomonitoring. Environ. Health Perspect. Suppl. 101 (1993) 37-42
172. Qu S.X., and Stacey N.H. Formation and persistence of DNA adducts in different target tissues of rats after multiple administration of benzo[a]pyrene. Carcinogenesis 17 (1996) 53-59
173. Walker V.E., Fennell T.R., Upton P.B., Skopek T.R., Prevost V., Shuker D.E.G., and Swenberg J.A. Molecular dosimetry of ethylene oxide: formation and persistence of 7-(2-hydroxyethyl) guanine in DNA following repeated exposures of rats and mice. Cancer Res. 52 (1992) 4328-4334
174. Valavanis C., Souliotis V.L., and Kyrtopoulos S.A. Differential effects of procarbazine and methyl nitrosourea on the accumulation of O6-methylguanine and the depletion abd recovery of O6-alkylguanine-DNA alkyltransferase in rat tissues. Carcinogenesis 15 (1994) 1681-1688
175. Ramesh A., and Knuckles M.E. Dose-dependent benzo(a)pyrene [B(a)P]-DNA adduct levels and persistence in F6344 rats following subchronic dietary exposure to B(a)P. Cancer Lett. 240 (2006) 268-278
176. Lyons B.P., Harvey J.S., and Parry J.M. An initial assessment of the genotoxic impact of the Sea Empress oil spill by the measurement of DNA adduct levels in the intertidal teleost Lipophrys pholis. Mutat. Res./Genetic Toxicol. Environ. Mutagen. 390 (1997) 263-268
177. Harvey J.S., Lyons B.P., Page T.S., Stewart C., and Parry J.M. An assessment of the genotoxic impact of the Sea Empress oil spill by the measurement of DNA adduct levels in selected invertebrate and vertebrate species. Mutat. Res./Genetic Toxicol. Environ. Mutagen. 441 (1999) 103-114
178. French B.L., Reichert W.L., Hom T., Nishimoto M., Sanborn H.R., and et Stein J.E. Accumulation and dose-response of hepatic DNA adducts in English sole (Pleuronectes vetulus) exposed to a gradient of contaminated sediments. Aquatic Toxicology 36 (1996) 1-16
179. Aas E., Baussant T., Balk L., Liewenborg B., Andersen E.T., and Pah O.K. Metabolites in bile, cytochrome P4501A and DNA adducts as environmental risk parameters for chronic oil exposure: a laboratory experiment with Atlantic cod. Aquat. Toxicol. 51 (2000) 241-258
180. Turesky R.J., and Markovic J. DNA adduct formation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in liver, kidney and colo-rectum of rats. Carcinogenesis 16 (1995) 2275-2279
181. Schut H.A.J., and Snyderwine E.G. DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. Carcinogenesis 20 (1999) 353-368
182. Yamashita K., Adachi M., Kato S., Nakagama H., Ochiai M., Wakabayashi K., Sato H., Nagao M., and Sugimura T. DNA-adducts formed by 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat liver:dose-response on chronic administration. Jpn. J. Cancer Res. 81 (1990) 470-476
183. Hirose M., Wakabayashi K., Ochiai M., Kushida H., Sato H., Sugimura T., and Nagao M. Formation and removal of DNA adducts in the liver of rats chronically fed the food-borne carcinogen, 2-amino-3,8dimethylimidazo[4,5-f]quinoxaline. Jpn. J. Cancer Res. 86 (1995) 516-522
184. Kushida T., Wakabayashi K., Sato H., Katami M., Kurosaka R., and Nagao M. Dose-response study of MeQIx carcinogenicity in F 344 male rats. Cancer Lett. 83 (1994) 31-35
185. Cummings D.A., and Schut H.A.J. Removal of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the male Fischer-344 rat. Carcinogenesis 15 (1994) 2623-2628
186. Fernando R.C., Schmeiser H.H., Scherf H.R., and Wiessler M. Formation and persistence of specific purine DNA adducts by 32P-postlabelling in target and non-target organs of rats treated with aristolochic acid I. IARC Sci. Publ. 124 (1993) 167-171
187. Nortier J.L., Muniz M.C., Schmeiser H.H., Arlt V.M., Bieler C.A., Petein M., Depierreux M.F., Depauw L., Abramowicz D., Vereerstraeten P., and Vanherweghem J.L. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia species). New Engl. J. Med. 342 (2000) 1686-1692
188. Arlt V.M., Alunni-Perret V., Quatrehomme G., Ohayon P., Albano L., Gaid H., Michiels J.F., Meyrier A., Cassuto E., Wiessler M., Schmeiser H.H., and Cosyns J.P. Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer. Int. J. Cancer 111 (2004) 977-980
189. Vanhaelen M., Vanhaelen-Fastre R., But P., and Vanherweghem J.-L. Identification of aristolochic acid in Chinese herbs. Lancet 343 (1994) 174
190. Vanherweghem J.-L., Depierreux M., Tielemans C., Abramowicz D., Dratwa M., Jadoul M., Richard C., Vandervelde D., Verbeelen D., Vanhaelen-Fastre R., and Vanhaelen M. Rapidly progressive interstitial renal fibrosis in young women - association with slimming regimen including Chinese herbs. Lancet 341 (1993) 387-391
191. Pfohl-Leszkowicz A., and Castegnaro M. Further arguments in favour of direct covalent binding of ochratoxin A (OTA) after metabolic biotransformation. Food Addit. Contam. Suppl. 1 (2005) 75-87
192. Castegnaro M., Mohr U., Pfohl-Leszkowicz A., Estève J., Steinmann J., Tillman J., Michelon J., and Bartsch H. Sex and strain-specific induction of renal tumours by ochratoxin A rats correlates with DNA adduction. Int. J. Cancer 77 (1998) 70-75
193. Pfohl-Leszkowicz A., Grosse Y., Kane A., Creppy E.E., and Dirheimer G. Differential DNA adduct formation and disappearance in three mice tissues after treatment by the mycotoxin, ochratoxin A. Mutat. Res. 289 (1993) 265-273
194. Poirier M.C., and Beland F.A. DNA adduct measurements and tumor incidence during chronic carcinogen exposure in animal models: Implications for DNA-adduct-based human cancer risk assessment. Toxicology 11/12 (1992) 749-755
195. Poirier M.C., and Beland F.A. DNA adduct measurements and tumor incidence during chronic carcinogen exposure in rodents. Environ. Health Perspect. 102 Suppl 6 (1994) 161-165
196. Poirier M.C. DNA adduct as exposure biomarkers and indicators of cancer risk. Environ. Health Perspect. 105 (1997) 907-912
197. M. C. Poirier. Chemical-induced DNA damage and Human cancer risk. www.nature.com/reviews/cancer, 4 (2004) 630-637.
198. Cui X.S., Torndal U.B., Eriksson L.C., and Möller L. Early formation of DNA adducts compared with tumor formation in a long term tumor study in rats after administration of 2-nitrofluorene. Carcinogenesis 16 (1995) 2135-2141
199. Decaprio A.P. Biomarkers: coming of age for environmental health and risk assessment. Environ. Sci. Technol. 31 (1997) 1837-1848
200. Izzotti A., Neri M., Vecchio D., and Puntoni R. Molecular epidemiology in cancer research (review). Int. J. Oncol. 11 (1997) 1053-1069
201. Singh R., and Farmer P.B. Liquid chromatography-electrospray ionization-mass spectrometry: the future of DNA adduct detection. Carcinogenesis 27 (2006) 178-196
202. D'arce L.P.G., and De Syllos Colus I.M. Cytogenetic and molecular biomonitoring of agricultural workers exposed to pesticides in Brazil. Teratogen. Carcinog. Mutagen. 20 (2000) 161-170
203. Eder E. Intra individual variations of DNA adduct levels in humans. Mutat. Res. 424 (1999) 249-261
204. Farmer P.B. Studies using specific biomarkers for human exposure assessment to exogenous and endogenous chemical agents. Mutat. Res. 428 (1999) 69-81
205. Talaska G., Maier A., Henn S., Booth-Jones A., Tsuneoka Y., Vermeulen R., and Schumann B.L. Carcinogen biomonitroing in human exposures and laboratory research: validation and application to human occupational exposures. Toxicol. Lett. 134 (2002) 39-49
206. Taningher M., Malacarne D., Mancuso T., Peluso M., Pescarolo M.P., and Parodi S. Methods for predicting carcinogenic hazards: new opportunities coming from recent developments in molecular oncology and SAR studies. Mutat. Res. 391 (1997) 3-32
207. Farmer P.B., and Shuker D.E.G. What is the significance of increases in background levels of carcinogen-derived protein and DNA adducts? Some considerations for incremental risk assessment. Mutat. Res. 424 (1999) 275-286
208. Farmer P.B. DNA and protein adducts as markers of genotoxicity. Toxicology 149 (2004) 3-9
209. Godschalk R.W.L., Van Schooten F.J., and Bartsch H. A critical evaluation of DNA adducts as biological markers for human exposure to polycyclic aromatic compounds. J. Biochem. Mol. Biol. 36 (2003) 1-11
210. Hemminki K., Koskinen M., Rajaniemi H., and Zhao C. DNA adducts, mutations and cancer 2000. Regul, Toxicol. Pharmacol. 32 (2000) 264-275
211. Hurdey S.E., and Krewski D. Is there a safe level of exposure to a carcinogen?. Environ. Sci. Technol. 29 (1995) 370-375
212. Sander M., Cadet J., Casciano D.A., Galloway S.M., Marnett L.J., Novak R.F., Pettit S.D., Preston R.J., Skare J.A., Williams G.M., Van Houten B., and Gollapudi B.B. Proceedings of a workshop on DNA adducts: biological significance and application to risk assessment Washington, DC, April 13-14 2004. Toxicol. Appl. Pharmacol. 208 (2005) 1-20
213. Swenberg J.A. Toxicological considerations in the application and interpretation of DNA adducts in epidemiological studies. IARC Sci. Publ. 157 (2004) 237-246
214. Hemminki K., and Thilly W.G. Implication of results of molecular epidemiology on DNA adducts, their repair and mutations for mechanisms of human cancer. IARC Sci. Publ. 157 (2004) 217-235
215. Wild C.P., and Turner P.C. The toxicology of aflatoxins as a basis for public health decisions. Mutagenesis 17 (2002) 471-481
216. Otteneder M., and Lutz W.K. Correlation of DNA adduct levels with tumor incidence: carcinogenic potency of DNA adducts. Mutat. Res. 424 (1999) 237-247
217. Krytopoulos S.A. Biomarkers in environmental carcinogenesis research: striving for a new momentum. Toxicol. Lett. 162 (2006) 3-15
218. Wild C.P., and Pisani P. Carcinogen DNA and protein adducts as biomarkers of human exposure in environmental cancer epidemiology. Cancer Detect. Prev. 22 (1998) 273-283
219. 1 mice fed a high w-3 fatty acid diet. Mutat. Res. 378 (1999) 23-30
220. Lutz W.K. Susceptibility differences in chemical carcinogenesis linearize the dose-response relationship threshold doses can be defined only for individuals. Mutat. Res. 482 (2001) 71-76
221. Lutz W.K. Statistical procedures to test linearity and estimate threshold doses for tumor induction with nonlinear dose-response relationships in bioassays for carcinogenicity. Regulatory Toxicol. Pharmacol. 36 (2002) 331-337
222. Lutz W.K., and Gaylor D. Significance of DNA adduct at low dose: shortening the time to spontaneous tumour occurrence. Regulatory Toxicol. Pharmacol. 23 (1996) 29-34
223. Poirier M.C., Santella R.M., and Wetson A. Carcinogen macromolecular adducts and their measurement. Carcinogenesis 21 (2000) 353-359
224. Poirier M.C., and Wetson A. Human DNA adduct measurements: state of art. Environ. Health Perspect. 104 Supp 5 (1996) 883-893